Search

everythinglearnresearchcommunity

for

Search:↓

Oral minoxidil can potentially increase hair growth in people suffering from Central Centrifugal Cicatricial Alopecia.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Azelaic acid treats acne, rosacea, and hyperpigmentation with minimal side effects.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

There is a significant need for better-validated quality of life tools in dermatology.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

The conclusion is that there's a link between high testosterone levels, insulin resistance, and certain skin conditions, regardless of obesity.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

The CWARTS tool is a promising method for assessing warts and could improve treatment and research.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

We need better research to improve alopecia treatment and patient care.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

Spironolactone helps reduce pain and lesions in hidradenitis suppurativa patients, and lower doses are also effective.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

People with hidradenitis suppurativa who are more resilient tend to have better quality of life and less anxiety and depression.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Effective wound healing after HS treatments can be achieved with various methods like moist dressings and skin grafting.

Certain surgical methods are better than routine incision for hidradenitis suppurativa, topical clindamycin and acitretin are effective treatments, men with HS have a risk of skin cancer, HS patients are more likely to die from heart problems, and specific genetic markers are linked to treatment response.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Skin health and diseases are closely linked to metabolic processes.